Evarts; Jerry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Evarts; Jerry.The latest application filed is for "crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1- -yl)-n-(pyridin-2-yl)benzamide".

Company Profile

10.19.26

Evarts; Jerry - Bellevue WA
EVARTS; Jerry - Seattle WA
Evarts; Jerry - Redmond WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1- -yl)-n-(pyridin-2-yl)benzamide App 20220177476 - Blatter; Frtiz ; et al.	2022-06-09
PROCESSES FOR THE PREPARATION OF 4-{8-AMINO-3-[(2S)-1-(BUT-2-YNOYL)-PYRROLIDIN-2-YL]IMIDAZO[1,5-a]-PYRAZIN- -1-YL}N-(PYRIDIN-2-YL)-BENZAMIDE App 20220127270 - BETHEL; Paul Allen ; et al.	2022-04-28
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-- yl)-N-(pyridin-2-yl)benzamide maleate Grant 11,059,829 - Blatter , et al. July 13, 2	2021-07-13
Process methods for phosphatidylinositol 3-kinase inhibitors Grant 10,954,199 - Bremner , et al. March 23, 2	2021-03-23
Imidazopyrazine inhibitors of Bruton's tyrosine kinase Grant 10,858,364 - Podoll , et al. December 8, 2	2020-12-08
Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1- -yl)-N-(pyridin-2-yl)benzamide malea App 20200255437 - Kind Code	2020-08-13
Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-- yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphoma Grant 10,640,509 - Blatter , et al.	2020-05-05
Process Methods For Phosphatidylinositol 3-kinase Inhibitors App 20200102277 - BREMNER; Stacy ; et al.	2020-04-02
Imidazopyrazine Inhibitors of Bruton's Tyrosine Kinase App 20190345164 - Podoll; Terry ; et al.	2019-11-14
Solid Forms and Formulations of Imidazopyrazine Compound App 20190337949 - Blatter; Fritz ; et al.	2019-11-07
Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-on- e Grant 10,442,805 - Buttar , et al. Oc	2019-10-15
Phosphatidylinositol 3-kinase inhibitors Grant 10,308,639 - Evarts , et al.	2019-06-04
Phosphatidylinositol 3-kinase inhibitors Grant 10,221,197 - Du , et al.	2019-03-05
Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide Grant 10,167,291 - Blatter , et al. J	2019-01-01
Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof Grant 10,059,677 - Bremner , et al. August 28, 2	2018-08-28
Process methods for phosphatidylinositol 3-kinase inhibitors Grant 10,047,060 - Bremner , et al. August 14, 2	2018-08-14
Solid Forms and Formulations of Imidazopyrazine Compound App 20180208596 - Blatter; Fritz ; et al.	2018-07-26
Process Methods For Phosphatidylinositol 3-kinase Inhibitors App 20180162826 - BREMNER; Stacy ; et al.	2018-06-14
Phosphatidylinositol 3-kinase Inhibitors App 20180065953 - Evarts; Jerry ; et al.	2018-03-08
Polymorphic Forms Of A Hydrochloride Salt Of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-on- E App 20180009811 - BUTTAR; Suzanne ; et al.	2018-01-11
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-- yl)-N-(pyridin-2-yl)benzamide Grant 9,796,721 - Blatter , et al. October 24, 2	2017-10-24
Phosphatidylinositol 3-kinase inhibitors Grant 9,765,060 - Evarts , et al. September 19, 2	2017-09-19
Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-on- e Grant 9,708,327 - Buttar , et al. July 18, 2	2017-07-18
Process Methods For Phosphatidylinositol 3-kinase Inhibitors App 20170107187 - BREMNER; Stacy ; et al.	2017-04-20
Process methods for phosphatidylinositol 3-kinase inhibitors Grant 9,567,337 - Bremner , et al. February 14, 2	2017-02-14
Solid Forms and Formulations of Imidazopyrazine Compound App 20170029428 - Blatter; Fritz ; et al.	2017-02-02
Polymorphic Forms Of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-on- E App 20160376274 - Carra; Ernest ; et al.	2016-12-29
Phosphatidylinositol 3-kinase inhibitors Grant 9,266,878 - Evarts , et al. February 23, 2	2016-02-23
Phosphatidylinositol 3-kinase Inhibitors App 20160039793 - Evarts; Jerry ; et al.	2016-02-11
Phosphatidylinositol 3-kinase Inhibitors App 20160024054 - Evarts; Jerry ; et al.	2016-01-28
Phosphatidylinositol 3-kinase Inhibitors App 20160016915 - Evarts; Jerry ; et al.	2016-01-21
Phosphatidylinositol 3-kinase inhibitors Grant 9,221,795 - Evarts , et al. December 29, 2	2015-12-29
Phosphatidylinositol 3-kinase Inhibitors App 20150361095 - Du; Zhimin ; et al.	2015-12-17
Phosphatidylinositol 3-kinase Inhibitors App 20150361070 - Evarts; Jerry ; et al.	2015-12-17
Phosphatidylinositol 3-kinase Inhibitors App 20150218154 - Evarts; Jerry ; et al.	2015-08-06
Process Methods For Phosphatidylinositol 3-kindase Inhibitors App 20150175605 - Bremner; Stacy ; et al.	2015-06-25
Phosphatidylinositol 3-kinase inhibitors Grant 9,029,384 - Evarts , et al. May 12, 2	2015-05-12
Phosphatidylinositol 3-kinase inhibitors Grant 9,018,221 - Evarts , et al. April 28, 2	2015-04-28
Phosphatidylinositol 3-kinase Inhibitors App 20140371246 - Evarts; Jerry ; et al.	2014-12-18
Phosphatidylinositol 3-kinase Inhibitors App 20140179718 - EVARTS; Jerry ; et al.	2014-06-26
Phosphatidylinositol 3-kinase Inhibitors App 20140179673 - EVARTS; Jerry ; et al.	2014-06-26
Atropisomers Of P13k-inhibiting Compounds App 20130324561 - Evarts; Jerry ; et al.	2013-12-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.